Date | Title | Description | |
---|---|---|---|
05 Nov 2021 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted on 3 and 4 November | Download |
03 Nov 2021 | On business and financial situation | The Company releases the first nine months 2021 financial results presentation | Download |
03 Nov 2021 | On business and financial situation | The Company releases the press release related to the first nine months 2021 financial results | Download |
21 Oct 2021 | Liquidity and counterparty agreements | Download | |
21 Oct 2021 | On business and financial situation | The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). | Download |
Pages
Date | Title | Description | |
---|---|---|---|
07 Nov 2019 | Information on P&L | ROVI releases the first nine months 2019 results presentation | Download |
03 Oct 2019 | Liquidity contracts and specialists | Liquidity contract: transactions conducted in the third quarter of 2019 | Download |
05 Sep 2019 | Others on business performance and financial information | The Company informs about the construction of a second heparin plant in Granada | Download |
30 Jul 2019 | Information on P&L | ROVI releases the first half 2019 results presentation | Download |
30 Jul 2019 | Information on P&L | ROVI releases the press release related to the first half 2019 financial results | Download |